Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

Market Cap	394.95B
Revenue (ttm)	221.09B
Net Income (ttm)	-15.39B
Shares Out	51.26M
EPS (ttm)	-300.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,489
Average Volume	96,841
Open	7,820.00
Previous Close	7,890.00
Day's Range	7,770.00 - 8,020.00
52-Week Range	6,400.00 - 19,750.00
Beta	2.13
RSI	46.49
Earnings Date	May 14, 2025

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1962
• Employees: 815
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 019170

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -15.39 billion, -73.16% less than in 2023.